Apparently, the peptide may also have better supported fibroblast survival under oxidative stress, a condition commonly present in injured tendon cell cultures
Researchers note that intranasal delivery may especially increase the bioavailability of peptide therapeutics and present an appealing alternative to injection [14, 15, 16]
Starting injections without a proper diagnosis is just guessing, and it could end up hiding other serious health issues
Inconsistent reconstitution leads to variable dosing, which makes it impossible to assess whether a peptide is actually working for your eczema or not
Canadian clinics are using compounding loopholes to promote unapproved drugs
Some animal studies have reported re-pigmentation in gray hair follicles following exposure to this compound, mediated through effects on melanocyte activity in the follicle